Letter: effectiveness of ustekinumab or vedolizumab in Crohn's disease following anti‐TNF failure—getting closer to the truth?
LINKED CONTENT This article is linked to Biemans et al papers. To view these articles, visit https://doi.org/10.1111/apt.15745 and https://doi.org/10.1111/apt.16062
Gespeichert in:
| Veröffentlicht in: | Alimentary pharmacology & therapeutics 2020-10, Vol.52 (7), p.1253-1254 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1254 |
|---|---|
| container_issue | 7 |
| container_start_page | 1253 |
| container_title | Alimentary pharmacology & therapeutics |
| container_volume | 52 |
| creator | Liu, Kecheng Cai, Fuqing Huang, Jiean |
| description | LINKED CONTENT
This article is linked to Biemans et al papers. To view these articles, visit https://doi.org/10.1111/apt.15745 and https://doi.org/10.1111/apt.16062 |
| doi_str_mv | 10.1111/apt.16009 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2448641625</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2440854888</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3659-539de0b6fb0462490aa9006858aad955c58109e2d38d38d1f9e3caf143bbcc7d3</originalsourceid><addsrcrecordid>eNp1kclKBDEQhoMoOC4H3yDgQT20Jr3ExIvI4AaDehjPTTpdcaKZzpikFT2JT-DBJ_RJzDieBIuCoqivNn6EtijZp8kO5CzuU0aIWEIDWrAqy0nBltGA5ExkOafFKloL4Z4Qwg5JPkDvI4gR_BEGrUFF8wQdhICdxn2I8GC6fiob7Dx-gtZZ8_qTmg4PvZt0OwG3JoAMgLWz1j2b7g7LLpqvt4_x1RnW0tjew9fb513aMi8q6wJ4HB2OE8DR93FyvIFWtLQBNn_jOro9Ox0PL7LR9fnl8GSUqfSHyKpCtEAaphtSsrwUREqRvuAVl7IVVaUqTomAvC343KkWUCipaVk0jVKHbbGOdhdzZ9499hBiPTVBgbWyA9eHOi9LzkrK8iqh23_Qe9f7Ll03pwivSs55ovYWlPIuBA-6nnkzlf6lpqSeq1EnNeofNRJ7sGCfjYWX_8H65Ga86PgG7YuPCQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2440854888</pqid></control><display><type>article</type><title>Letter: effectiveness of ustekinumab or vedolizumab in Crohn's disease following anti‐TNF failure—getting closer to the truth?</title><source>Wiley Online Library Free Content</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Wiley Online Library All Journals</source><creator>Liu, Kecheng ; Cai, Fuqing ; Huang, Jiean</creator><creatorcontrib>Liu, Kecheng ; Cai, Fuqing ; Huang, Jiean</creatorcontrib><description>LINKED CONTENT
This article is linked to Biemans et al papers. To view these articles, visit https://doi.org/10.1111/apt.15745 and https://doi.org/10.1111/apt.16062</description><identifier>ISSN: 0269-2813</identifier><identifier>EISSN: 1365-2036</identifier><identifier>DOI: 10.1111/apt.16009</identifier><language>eng</language><publisher>Chichester: Wiley Subscription Services, Inc</publisher><subject>Crohn's disease ; Monoclonal antibodies</subject><ispartof>Alimentary pharmacology & therapeutics, 2020-10, Vol.52 (7), p.1253-1254</ispartof><rights>2020 John Wiley & Sons Ltd</rights><rights>Copyright © 2020 John Wiley & Sons Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3659-539de0b6fb0462490aa9006858aad955c58109e2d38d38d1f9e3caf143bbcc7d3</citedby><cites>FETCH-LOGICAL-c3659-539de0b6fb0462490aa9006858aad955c58109e2d38d38d1f9e3caf143bbcc7d3</cites><orcidid>0000-0003-2163-3563</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fapt.16009$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fapt.16009$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,1433,27924,27925,45574,45575,46409,46833</link.rule.ids></links><search><creatorcontrib>Liu, Kecheng</creatorcontrib><creatorcontrib>Cai, Fuqing</creatorcontrib><creatorcontrib>Huang, Jiean</creatorcontrib><title>Letter: effectiveness of ustekinumab or vedolizumab in Crohn's disease following anti‐TNF failure—getting closer to the truth?</title><title>Alimentary pharmacology & therapeutics</title><description>LINKED CONTENT
This article is linked to Biemans et al papers. To view these articles, visit https://doi.org/10.1111/apt.15745 and https://doi.org/10.1111/apt.16062</description><subject>Crohn's disease</subject><subject>Monoclonal antibodies</subject><issn>0269-2813</issn><issn>1365-2036</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp1kclKBDEQhoMoOC4H3yDgQT20Jr3ExIvI4AaDehjPTTpdcaKZzpikFT2JT-DBJ_RJzDieBIuCoqivNn6EtijZp8kO5CzuU0aIWEIDWrAqy0nBltGA5ExkOafFKloL4Z4Qwg5JPkDvI4gR_BEGrUFF8wQdhICdxn2I8GC6fiob7Dx-gtZZ8_qTmg4PvZt0OwG3JoAMgLWz1j2b7g7LLpqvt4_x1RnW0tjew9fb513aMi8q6wJ4HB2OE8DR93FyvIFWtLQBNn_jOro9Ox0PL7LR9fnl8GSUqfSHyKpCtEAaphtSsrwUREqRvuAVl7IVVaUqTomAvC343KkWUCipaVk0jVKHbbGOdhdzZ9499hBiPTVBgbWyA9eHOi9LzkrK8iqh23_Qe9f7Ll03pwivSs55ovYWlPIuBA-6nnkzlf6lpqSeq1EnNeofNRJ7sGCfjYWX_8H65Ga86PgG7YuPCQ</recordid><startdate>202010</startdate><enddate>202010</enddate><creator>Liu, Kecheng</creator><creator>Cai, Fuqing</creator><creator>Huang, Jiean</creator><general>Wiley Subscription Services, Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>7U9</scope><scope>H94</scope><scope>M7N</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-2163-3563</orcidid></search><sort><creationdate>202010</creationdate><title>Letter: effectiveness of ustekinumab or vedolizumab in Crohn's disease following anti‐TNF failure—getting closer to the truth?</title><author>Liu, Kecheng ; Cai, Fuqing ; Huang, Jiean</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3659-539de0b6fb0462490aa9006858aad955c58109e2d38d38d1f9e3caf143bbcc7d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Crohn's disease</topic><topic>Monoclonal antibodies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Liu, Kecheng</creatorcontrib><creatorcontrib>Cai, Fuqing</creatorcontrib><creatorcontrib>Huang, Jiean</creatorcontrib><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>MEDLINE - Academic</collection><jtitle>Alimentary pharmacology & therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liu, Kecheng</au><au>Cai, Fuqing</au><au>Huang, Jiean</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Letter: effectiveness of ustekinumab or vedolizumab in Crohn's disease following anti‐TNF failure—getting closer to the truth?</atitle><jtitle>Alimentary pharmacology & therapeutics</jtitle><date>2020-10</date><risdate>2020</risdate><volume>52</volume><issue>7</issue><spage>1253</spage><epage>1254</epage><pages>1253-1254</pages><issn>0269-2813</issn><eissn>1365-2036</eissn><abstract>LINKED CONTENT
This article is linked to Biemans et al papers. To view these articles, visit https://doi.org/10.1111/apt.15745 and https://doi.org/10.1111/apt.16062</abstract><cop>Chichester</cop><pub>Wiley Subscription Services, Inc</pub><doi>10.1111/apt.16009</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0003-2163-3563</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0269-2813 |
| ispartof | Alimentary pharmacology & therapeutics, 2020-10, Vol.52 (7), p.1253-1254 |
| issn | 0269-2813 1365-2036 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2448641625 |
| source | Wiley Online Library Free Content; EZB-FREE-00999 freely available EZB journals; Wiley Online Library All Journals |
| subjects | Crohn's disease Monoclonal antibodies |
| title | Letter: effectiveness of ustekinumab or vedolizumab in Crohn's disease following anti‐TNF failure—getting closer to the truth? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T21%3A24%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Letter:%20effectiveness%20of%20ustekinumab%20or%20vedolizumab%20in%20Crohn's%20disease%20following%20anti%E2%80%90TNF%20failure%E2%80%94getting%20closer%20to%20the%20truth?&rft.jtitle=Alimentary%20pharmacology%20&%20therapeutics&rft.au=Liu,%20Kecheng&rft.date=2020-10&rft.volume=52&rft.issue=7&rft.spage=1253&rft.epage=1254&rft.pages=1253-1254&rft.issn=0269-2813&rft.eissn=1365-2036&rft_id=info:doi/10.1111/apt.16009&rft_dat=%3Cproquest_cross%3E2440854888%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2440854888&rft_id=info:pmid/&rfr_iscdi=true |